Vimarsana
Biggest News Aggregation in the World

Hematology Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hematology Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hematology Program Today - Breaking & Trending Today

KPIX KPIX 5 News Early Edition January 28, 2016 - Vimarsana News

KPIX KPIX 5 News Early Edition January 28, 2016

Down for at least the next half hour. Other than that, quiet into San Francisco. Super bowl closures coming up. A gruesome twist in a south bay murder case. Kpix 5s Christin Ayers on the new clues that suggest a missing campbell man has been killed. Reporter volunteers wrapped up a search of this area and the Santa Cruz Mountains with still no sign of kyle myrick. He went missing from his job at gp sports friday. He had been working alongside this man, steve hlebo appeared in court in san jose accused of murder even though authorities have yet to find the body. The gory details of what they di...

KPIX KPIX 5 News At 6AM January 28, 2016 - Vimarsana News

KPIX KPIX 5 News At 6AM January 28, 2016

This to say. I just wish he would be a man and tell me where my brother is. Reporter the family will be back here in front of the luckies at cam dell and union avenues in san jose at 8 a. M. Kiet do, kpix 5. What do Police Need Help with right now . Reporter so they want anybody who spotted that truck again its a 2003 dark gray gmc sierra and specifically the time frame where they want anybody who saw it was friday 6 p. M. Until saturday morning at 2 a. M. , if you saw the truck or know anything at this point, call san jose police. Live in san jose, kiet do, kpix 5. We are just 10 days away fr...

VIC-1911 With/Without Sotorasib Under Investigation in KRAS G12C Inhibitor–Resistant and –Naïve NSCLC - Vimarsana News

VIC-1911 With/Without Sotorasib Under Investigation in KRAS G12C Inhibitor–Resistant and –Naïve NSCLC

Sarah Goldberg, MD, MPH, highlights the mechanism of action of VIC-1911, expands on its ongoing investigation in the phase 1 trial, and sheds light on next steps planned for the agent’s investigation in KRAS G12C–mutant non–small cell lung cancer.

Dr Goldberg on the Investigation of VIC-1911 With/Without Sotorasib in KRAS G12C-Mutant NSCLC - Vimarsana News

Dr Goldberg on the Investigation of VIC-1911 With/Without Sotorasib in KRAS G12C-Mutant NSCLC

Sarah Goldberg, MD, MPH, discusses the design and key objectives of an ongoing phase 1a/b study of VIC-1911 as a monotherapy and in combination with sotorasib in KRAS G12C–mutant non–small cell lung cancer.

Dr Goldberg on Investigational Agents in EGFR-mutant NSCLC - Vimarsana News

Dr Goldberg on Investigational Agents in EGFR-mutant NSCLC

Sarah Goldberg, MD, MPH, discusses ongoing investigations with antibody-drug conjugates and bispecific antibodies in patients with non–small cell lung cancer harboring EGFR mutations.